Thank you very much!

🎉 15 researchers at The Institute have received @FRQS1 salary awards — more than $2.5M for work spanning cancer, infectious diseases, child health, neurology, maternal health, and more. Congratulations to all recipients! 👉 rimuhc.ca/en/-/frq-competiti…

Je tiens à remercier le @Fonds de recherche du Québec @FRQS1 de soutenir ma carrière en recherche. Comme moi, joignez votre voix à celle de la #communautéFRQ et affichez votre soutien à la recherche ! > communautefrq.ca

🚨Primary Care Physicians 🚨 Join #DHS2026: Challenging Evidence 🧠💊 📍 Melbourne | 📅 23–25 Oct ✔️ Primary care–focused sessions ✔️ Practical skills and cases ✔️ Global experts real-world insights Bring #drugallergy #antibioticallergy knowledge and care into your practice. 👉 dhs2026.org/ @RACGP #GPeducation #PrimaryCare #CPD @TheDohertyInst @EAACI_HQ

What an incredible morning in Antwerp! 🇧🇪 PROSPECTOR-2 Investigator Meeting brought together a global team united by one mission — transforming testing for penicillin allergy. The work continues! #PROSPECTOR #PenicillinDelabeling #AntibioticStewardship

Excited to have hosted a PROSPECTOR-2 Investigator Meeting in Antwerp today! 🌍 Investigators from countries across Africa, Asia, Australia, Canada & Europe came together. Grateful for this incredible team. #DrugAllergy #PenicillinAllergy #ClinicalTrials #PROSPECTOR

Big few weeks with #PENFAST making it to Hollywood 🎥… but this might be even better 👇 The @ProspectorTrial #PROSPECTOR1 Trial led by @Austin_Health and @TheDohertyInst is now published in @NEJMEvidence 🔥 ➡️ evidence.nejm.org/doi/full/1… ✅ First double-blind, placebo-controlled trial in #drugallergy ✅ Pilot feasibility RCT (n=120) ✅ Single-dose vs 5-day amoxicillin challenge in delayed/unknown #penicillinallergy It was feasible and safe — and showed a 6.7% increase in immune-mediated reactions in the (multi-dose) arm. Nice Editorial: ➡️ evidence.nejm.org/doi/full/1… We’re getting closer to answering the question… Is one dose ever enough? 👀 #PROSPECTOR2 now recruiting (doi: 10.1136/bmjopen-2024-094712)

Check out the program for #DHS2026 @EAACI_HQ @TheDohertyInst 😳😍All things #drugallergy and #antibioticallergy. See you in Melbourne!! ☕️🦘☀️🇦🇺 🔜 dhs2026.org 

🔍 Did you know?
PROSPECTOR helps us move beyond assumptions. What is the role of prolonged penicillin drug challenge?
#DrugAllergy #EvidenceBasedMedicine

And finally, the no. 1️⃣ most viewed Radiology article of the year: a consensus statement from @RadiologyACR and @AAAAI_org on how to prevent and manage hypersensitivity reactions to radiocontrast media! Check it out here: bit.ly/4d5rWwB

🚨SAVE THE DATE 🚨Drug Hypersensitivity Symposium - Challengjng Evidence #DHS2026. 0ct 23-25 2026. What a perfect excuse to come down under 🦘🐨🇦🇺 Partnering with @EAACI_HQ. Great line up… stay tuned dhs2026.org @CAAR_Aus @TheDohertyInst

Excited to share our new review in JACI: IP! We explore safety, timing, and practical guidance for managing penicillin allergy in pregnant patients. pubmed.ncbi.nlm.nih.gov/4131… #PenicillinAllergy #PregnancyCare #allergy @IDIGHProgram & @McGill_DOM

Grateful for the opportunity to contribute to this article on drug allergy delabeling alongside such incredible co-authors! Collaborations like this push the field forward and improve patient care. #DrugAllergy #Delabeling #TeamWork @IDIGHProgram & @McGill_DOM!

Well done @Elise_Mitri & Friends on this hopefully helpful #antibioticallergy resource 👏 - focused for #AMS and #ID folk looking to start, build ot extend programs! State-of-the-Art Review: Antibiotic Allergy—A Multidisciplinary Approach to Delabeling academic.oup.com/cid/article…

Thrilled to receive the Early Career Award from @CSACI_ca! 🏆 Grateful to my mentors @TrubianoJason, colleagues & patients. Excited to keep advancing drug allergy research with @IDIGHProgram & @McGill_DOM! 💡 #CSACI #DrugAllergy #McGillResearch 🔗 mcgill.ca/deptmedicine/artic…

Is one dose ever enough? @ProspectorTrial will answer - A international double blind placebo controlled trial of 1 dose vs 5 day for #penicillinallergy. This week we recruited our 100th patient. @CAAR_Aus @Austin_Health @TheDohertyInst

👩‍⚕️ Clinicians: Should we consider prolonged penicillin challenge for patients with unclear histories?
PROSPECTOR will answer this important clinical question
#ClinicalImmunology #AllergyToolkit

🧪 A step forward in de-labeling and precision allergy care.
📍 Multicenter | 🔍 Real-world impact | 💊 Antibiotic stewardship Stay tuned for updates! #DrugAllergy #Penicillin #AllergyResearch #PROSPECTORTrial

📢Prolonged versus single dose in penicillin oral challenge testing @ProspectorTrial 👏👏👏@TrubianoJason @AnaCopaescu @lenehgarvey @mcgillu #isonedoseenough #penicillinallergy @Austin_Health @CAAR_Aus @TheDohertyInst bmjopen.bmj.com/content/15/2…

@ProspectorTrial activated in 🇨🇦 with @AnaCopaescu leading at @mcgillu - our 2nd international site 🌎 #isonedoseenough #penicillinallergy @Austin_Health @CAAR_Aus @TheDohertyInst

New Call for Applications & Gala Pictures - mailchi.mp/48d7cc18e050/even…